Efficacy of a Video-Based Educational Program on Female Urinary Incontinence
Launched by POITIERS UNIVERSITY HOSPITAL · Jul 29, 2025
Trial Information
Current as of August 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a 4-week video-based education program can help reduce the symptoms of urinary incontinence (unintentional urine leakage) in women before they start pelvic floor muscle exercises with a physiotherapist. Researchers want to see if watching educational videos works better than reading similar information on paper in improving bladder control. After the education program or reading the paper, all participants will go through their usual pelvic floor rehabilitation sessions, and their progress will be tracked through questionnaires and follow-ups up to two years later.
Women who are 18 years or older, have been referred for pelvic floor rehabilitation because of urinary leakage, and have access to a smartphone, tablet, or computer with email are eligible to join. Participants will either watch the video program or receive a printed information sheet before starting their therapy. They will complete questionnaires about their symptoms at different times during and after the program. Some women, such as those with certain medical conditions, recent childbirth, or who cannot use the video or questionnaires, will not be able to join. This study is not yet recruiting but aims to find out if a video-based approach can be a helpful first step in managing urinary incontinence.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Any woman referred for pelvic floor rehabilitation sessions for urinary incontinence (defined as 'any involuntary leakage reported by the patient' according to the International Continence Society)
- • Women requiring perineal rehabilitation for urinary incontinence
- • Aged 18 years or older
- • Having access to a connected device (tablet, smartphone, computer)
- • Having a functional email address
- • Covered by a social security scheme
- • Informed, and written consent (signed by the participant and the investigator)
- Exclusion Criteria:
- • Women unable to complete questionnaires (unable to read French or unable to write)
- • Visually impaired individuals who cannot watch the video or read the printed material
- • Genital prolapse extending beyond the hymen
- • Documented neurological disorders
- • Individuals receiving psychiatric care and those unable to express their consent
- • History of pelvic fractures or dorsolumbar surgery
- • Chronic pelvic pain
- • Women who have given birth within the last 6 month
- • Individuals with enhanced protection: minors, individuals deprived of liberty, individuals residing in a health or social institution, pregnant or breastfeeding women, adults under legal protection, and patients in emergency situations.
About Poitiers University Hospital
Poitiers University Hospital is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to explore new therapeutic interventions and improve patient outcomes. With a commitment to ethical standards and patient safety, Poitiers University Hospital collaborates with healthcare professionals, researchers, and institutions to facilitate groundbreaking studies that contribute to medical knowledge and enhance treatment protocols across various specialties.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Anne Cecile Pizzoferrato, M.D
Study Director
University Hospital Center of Poitiers
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported